(Hypertension. 1997;30:358.)
© 1997 American Heart Association, Inc.
Articles |
From the Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Correspondence to Masashi Mukoyama, MD, PhD, Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606, Japan. E-mail muko{at}kuhp.kyoto-u.ac.jp
Abstract Angiotensin II acts on at least two receptor subtypes, AT1 and AT2. Although the physiological role of the AT2 receptor is still poorly defined, it may be implicated in inhibition of cell growth, vasorelaxation, and apoptosis. In the present study, to investigate the role of the AT2 receptor in the kidney and its implication in hypertensive states, we examined its expression using cultured mesangial cells (MC) from normotensive Wistar-Kyoto rats (WKY) and from stroke-prone spontaneously hypertensive rats (SHRSP). Receptor binding assays were performed using a nonselective ligand, [Sar1,Ile8]angiotensin II, or AT2-selective CGP42112A. Binding assays revealed that MC from WKY exhibited both AT1 and AT2 receptors, the ratio of which was confluence-dependent. In contrast, MC from SHRSP, whose proliferation activity was much higher than those from WKY, showed only the AT1 subtype. In receptor binding and Northern blot analyses, expression of the AT2 receptor of WKY-MC was low in the growing state but significantly induced upon confluence to become abundant in the postconfluent state, whereas that of SHRSP-MC was undetectable in either state. Gene expressions of AT1A and AT1B receptors were not significantly altered in either strain during the time in culture. These results indicate that the mesangial AT2-receptor expression is growth-dependent and suggest a role in the inhibition of MC growth in WKY. Much lower expression of the AT2 receptor in MC from SHRSP may suggest involvement in their higher proliferation activity and possibly in consequent renal disorders.
Key Words: receptors, angiotensin angiotensin II mesangium, glomerular rats, inbred SHR
This article has been cited by other articles:
![]() |
J. Weissgarten, S. Berman, S. Efrati, M. Rapoport, Z. Averbukh, and L. Feldman Apoptosis and proliferation of cultured mesangial cells isolated from kidneys of rosiglitazone-treated pregnant diabetic rats Nephrol. Dial. Transplant., May 1, 2006; 21(5): 1198 - 1204. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. McMullen and S. C. Langley-Evans Maternal low-protein diet in rat pregnancy programs blood pressure through sex-specific mechanisms Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2005; 288(1): R85 - R90. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Ahmed, A. K. Kang, K. D. Burns, C. R. J. Kennedy, V. Lai, D. C. Cattran, J. W. Scholey, and J. A. Miller Effects of Oral Contraceptive Use on the Renal and Systemic Vascular Response to Angiotensin II Infusion J. Am. Soc. Nephrol., March 1, 2004; 15(3): 780 - 786. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Armando, M. Jezova, A. V. Juorio, J. A. Terron, A. Falcon-Neri, C. Semino-Mora, H. Imboden, and J. M. Saavedra Estrogen upregulates renal angiotensin II AT2 receptors Am J Physiol Renal Physiol, November 1, 2002; 283(5): F934 - F943. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Lorenzo, M. Ruiz-Ortega, Y. Suzuki, M. Ruperez, V. Esteban, T. Sugaya, and J. Egido Angiotensin III Activates Nuclear Transcription Factor-{kappa}B in Cultured Mesangial Cells Mainly via AT2 Receptors: Studies with AT1 Receptor-Knockout Mice J. Am. Soc. Nephrol., May 1, 2002; 13(5): 1162 - 1171. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Suganami, M. Mukoyama, A. Sugawara, K. Mori, T. Nagae, M. Kasahara, K. Yahata, H. Makino, Y. Fujinaga, Y. Ogawa, et al. Overexpression of Brain Natriuretic Peptide in Mice Ameliorates Immune-Mediated Renal Injury J. Am. Soc. Nephrol., December 1, 2001; 12(12): 2652 - 2663. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Berry, R. Touyz, A. F. Dominiczak, R. C. Webb, and D. G. Johns Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2337 - H2365. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ruiz-Ortega, O. Lorenzo, M. Ruperez, J. Blanco, and J. Egido Systemic Infusion of Angiotensin II into Normal Rats Activates Nuclear Factor-{{kappa}}B and AP-1 in the Kidney : Role of AT1 and AT2 Receptors Am. J. Pathol., May 1, 2001; 158(5): 1743 - 1756. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Moore, N. T. Heiderstadt, E. Huang, N. L. Howell, Z.-Q. Wang, H. M. Siragy, and R. M. Carey Selective Inhibition of the Renal Angiotensin Type 2 Receptor Increases Blood Pressure in Conscious Rats Hypertension, May 1, 2001; 37(5): 1285 - 1291. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Schwobel, T. Fischer, B. Lanz, and M. Mohaupt Angiotensin II receptor subtypes determine induced NO production in rat glomerular mesangial cells Am J Physiol Renal Physiol, December 1, 2000; 279(6): F1092 - F1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. de Gasparo, K. J. Catt, T. Inagami, J. W. Wright, and Th. Unger International Union of Pharmacology. XXIII. The Angiotensin II Receptors Pharmacol. Rev., September 1, 2000; 52(3): 415 - 472. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Arima and S. Ito Angiotensin II type 2 receptors in the kidney: evidence for endothelial-cell-mediated renal vasodilatation Nephrol. Dial. Transplant., April 1, 2000; 15(4): 448 - 451. [Full Text] [PDF] |
||||
![]() |
F. L. Day, L. A. Rafty, C. N. Chesterman, and L. M. Khachigian Angiotensin II (ATII)-inducible Platelet-derived Growth Factor A-chain Gene Expression Is p42/44 Extracellular Signal-regulated Kinase-1/2 and Egr-1-dependent and Mediated via the ATII Type 1 but Not Type 2 Receptor. INDUCTION BY ATII ANTAGONIZED BY NITRIC OXIDE J. Biol. Chem., August 20, 1999; 274(34): 23726 - 23733. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Amiri and R. Garcia Regulation of angiotensin II receptors and PKC isoforms by glucose in rat mesangial cells Am J Physiol Renal Physiol, May 1, 1999; 276(5): F691 - F699. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Horiuchi, M. Akishita, and V. J. Dzau Recent Progress in Angiotensin II Type 2 Receptor Research in the Cardiovascular System Hypertension, February 1, 1999; 33(2): 613 - 621. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-Q. Wang, L. J. Millatt, N. T. Heiderstadt, H. M. Siragy, R. A. Johns, and R. M. Carey Differential Regulation of Renal Angiotensin Subtype AT1A and AT2 Receptor Protein in Rats With Angiotensin-Dependent Hypertension Hypertension, January 1, 1999; 33(1): 96 - 101. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Matsubara Pathophysiological Role of Angiotensin II Type 2 Receptor in Cardiovascular and Renal Diseases Circ. Res., December 14, 1998; 83(12): 1182 - 1191. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |